特应性皮炎治疗药物应用管理专家共识(2024版)  

Expert consensus on the application and management of therapeutic drugs for atopic dermatitis(2024)

作　　者：中国医师协会皮肤科医师分会 中华医学会皮肤性病学分会 中国医疗保健国际交流促进会皮肤医学分会 疑难重症及罕见病国家重点实验室 国家皮肤与免疫疾病临床医学研究中心 晋红中[2] 高兴华[3] 吴超[2] China Dermatologist Association;Chinese Society of Dermatology;Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care;State Key Laboratory of Complex Severe and Rare Diseases;National Clinical Research Center for Dermatologic and Immunologic Diseases;Jin Hongzhong;Gao Xinghua

机构地区：[1]不详 [2]中国医学科学院北京协和医院 [3]中国医科大学附属第一医院

出　　处：《中华皮肤科杂志》2024年第2期97-108,共12页Chinese Journal of Dermatology

基　　金：中央高水平医院临床科研业务费(2022-PUMCH-B-092);国家重点研发计划项目(2022YFC3601800)。

摘　　要：特应性皮炎是一种常见的慢性复发性炎症性皮肤病,既往治疗药物包括外用糖皮质激素、外用钙调磷酸酶抑制剂、口服抗组胺药、系统性免疫抑制剂及糖皮质激素等。近年来,生物制剂及多种小分子药物陆续获批用于本病的治疗。中国医师协会皮肤科医师分会、中华医学会皮肤性病学分会、中国医疗保健国际交流促进会皮肤医学分会、疑难重症及罕见病国家重点实验室和国家皮肤与免疫疾病临床医学研究中心组织专家,基于近年特应性皮炎研究进展及国内外指南/共识,结合专家临床经验,针对特应性皮炎治疗药物的临床应用策略、不良反应监测及管理、特殊人群用药管理等内容形成特应性皮炎治疗药物应用管理专家共识。Atopic dermatitis is a common chronic recurrent inflammatory skin disease.Previous therapeutic drugs include topical glucocorticoids,topical calcineurin inhibitors,oral antihistamines,systemic immunosuppressants and glucocorticoids,etc.In recent years,biologics and a variety of small-molecule drugs have been approved for the treatment of atopic dermatitis.Based on recent research progress,Chinese and international guidelines or consensus,and experts′clinical experience,China Dermatologist Association,Chinese Society of Dermatology,Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care,State Key Laboratory of Complex Severe and Rare Diseases,and National Clinical Research Center for Dermatologic and Immunologic Diseases convened experts to develop this consensus on strategies for the clinical application of therapeutic drugs for atopic dermatitis,monitoring and management of adverse drug reactions,and drug management in special populations,aiming to provide a reference for the application and management of therapeutic drugs for atopic dermatitis.

关 键 词：皮炎 特应性 药物疗法管理 生物制剂 分子靶向治疗 药物毒性 特殊人群 专家共识 

分 类 号：R969[医药卫生—药理学]